You are here

  • Home
  • Archive
  • Volume 12, Issue 7
  • ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside

Article info

Article menu
Immunotherapy biomarkers
Original research
ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside

Authors

  • Ming Zhou Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Bei Chen Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Chenxi Lu Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Jinhui Yang Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Peng Liu Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaKey Laboratory of Biological Nanotechnology of National Health Commission, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Xiaobo Wang Department of Nuclear Medicine and State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Shuo Hu Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaKey Laboratory of Biological Nanotechnology of National Health Commission, Changsha, Hunan, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles

Citation

Zhou M, Chen B, Lu C, et al
ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside
Journal for ImmunoTherapy of Cancer 2024;12:e009153. doi: 10.1136/jitc-2024-009153
Online issue publication 
July 25, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.